Filing Details

Accession Number:
0000914190-21-000374
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-09-24 16:30:53
Reporting Period:
2021-09-22
Accepted Time:
2021-09-24 16:30:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
842023 Bio-Techne Corp TECH Biological Products, (No Disgnostic Substances) (2836) 411427402
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1739054 Kim Kelderman 614 Mckinley Place Ne
Minneapolis MN 55413
Pres. Diagnostics & Genom No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-09-22 822 $529.04 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Options (Right to Buy) $150.78 2025-05-01 2,652 2,652 Direct
Common Stock Stock Options (Right to Buy) $150.78 2025-05-01 7,348 7,348 Direct
Common Stock Stock Options (Right to Buy) $177.32 2025-08-08 12,044 12,044 Direct
Common Stock Stock Options (Right to Buy) $177.32 2025-08-08 9,033 9,033 Direct
Common Stock Restricted Stock Units $0.00 2,363 2,363 Direct
Common Stock Stock Options (Right to Buy) $190.41 2026-08-07 11,961 11,961 Direct
Common Stock Stock Options (Right to Buy) $190.41 2026-08-07 15,948 15,948 Direct
Common Stock Restricted Stock Units $0.00 2,015 2,015 Direct
Common Stock Stock Options (Right to Buy) $267.87 2027-08-05 8,991 8,991 Direct
Common Stock Stock Options (Right to Buy) $267.87 2027-08-05 11,988 11,988 Direct
Common Stock Stock Options (Right to Buy) $267.87 2027-08-05 8,325 8,325 Direct
Common Stock Stock Options (Right to Buy) $267.87 2027-08-05 8,325 8,325 Direct
Common Stock Restricted Stock Units $0.00 1,245 1,245 Direct
Common Stock Stock Options (Right to Buy) $481.82 2028-08-06 4,864 4,864 Direct
Common Stock Stock Options (Right to Buy) $481.82 2028-08-06 6,486 6,486 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2025-05-01 2,652 2,652 Direct
2025-05-01 7,348 7,348 Direct
2025-08-08 12,044 12,044 Direct
2025-08-08 9,033 9,033 Direct
2,363 2,363 Direct
2026-08-07 11,961 11,961 Direct
2026-08-07 15,948 15,948 Direct
2,015 2,015 Direct
2027-08-05 8,991 8,991 Direct
2027-08-05 11,988 11,988 Direct
2027-08-05 8,325 8,325 Direct
2027-08-05 8,325 8,325 Direct
1,245 1,245 Direct
2028-08-06 4,864 4,864 Direct
2028-08-06 6,486 6,486 Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2021.
  2. Options to purchase 663 shares vest on each of 5/1/2019, 5/1/2020, 5/1/2021 and 5/1/2022.
  3. Options to purchase 1,837 shares vest on each of 5/1/2019, 5/1/2020, 5/1/2021 and 5/1/2022.
  4. Options to purchase 3,011 shares vest on each of 8/8/2019, 8/8/2020, 8/8/2021 and 8/8/2022.
  5. Fully exercisable.
  6. Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
  7. Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
  8. Options to purchase 3,987 shares vest on each of 8/7/2020, 8/7/2021, 8/7/2022 and 8/7/2023.
  9. Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
  10. Options to purchase 2,997 shares vest on each of 8/5/2021, 8/5/2022, 8/5/2023 and 8/5/2024.
  11. Options to purchase 2,775 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023.
  12. Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021.
  13. Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
  14. Options to purchase 1,621 shares vest on each of 8/6/2022 and 8/6/2023 and options to purchase 1,622 shares vest on each of 8/6/2024 and 8/6/2025.